Latest in Research & Development

Rice University scientists create hydrogel platform for precision, long-lasting drug delivery

The researchers have developed a peptide hydrogel system that slows and extends drug release, improving treatment adherence and efficacy across therapies ranging from tuberculosis medication to insulin

Find out more

Cytiva and WhiteLab Genomics team up to use AI to accelerate cell line development

Collaboration will accelerate stable cell line development in AAV genomic medicine development and ultimately also shorten the development timeline to clinic
See more

Simris Biologics secures €200K funding to develop microcystin-based payloads for antibody-drug conjugates

The Berlin-based subsidiary will use the grant to advance the KlicMic R&D programme, creating targeted microcystin payloads for ADCs that aim to improve cancer therapy efficacy whilst reducing side effects

Merck scraps £1bn UK expansion amid concerns as warnings mount over UK’s life sciences competitiveness

The company cited underinvestment in life sciences and the undervaluation of innovative medicines for the decision, raising questions about the UK’s competitiveness in pharmaceutical research and production

Phesi analysis finds GLP-1 therapies now being studied across more than 100 diseases

New data from Phesi reveals the rapid expansion of GLP-1 research beyond obesity, with the findings highlighting the potential of GLP-1s to reshape disease prevention, clinical trial design and patient care

Nanobodies against cancer: new research project at the UDE

Medicines Discovery Catapult and Crown Bioscience forge global alliance to advance radiopharmaceutical innovation

The partnership will create an integrated translational biology platform to accelerate the development of next-generation radiopharmaceuticals for cancer diagnosis and treatment

New NICE thresholds: good news for rare disease drugs but process remains complex

Recent changes introduced by NICE will ultimately see more ultra-rare disease drugs get to market, but Dan Williams, CEO at SynaptixBio, says the process remains challenging

Oncolytics Biotech announces positive clinical data for metastatic colorectal cancer trial

The latest results could accelerate the company's path to registration after the FDA's Breakthrough Therapy designations created momentum for companies advancing pioneering oncology platforms

Continuous innovation: redefining the future of pharmaceutical manufacturing

In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced

Latest posts in Research & Development

Servier acquires potential treatment for Fragile X syndrome

KER-0193, a novel, orally bioavailable small molecule, was granted orphan drug and rare paediatric drug designation by the US FDA

Intranasal GLP-1 medication from Orexo shows positive results in preclinical trial

Orexo's AmorphOX technology had positive results when compared against oral and injectable formulations in the study

Weight-loss drug semaglutide reduces cocaine use in rats

New study results suggest possible first pharmacological treatment for human cocaine dependency

Servier and IDEAYA Biosciences join forces to bring a promising new eye cancer treatment to patients across the globe

Servier and IDEAYA Biosciences have entered into an exclusive license agreement for regulatory and commercial rights to darovasertib outside the US

Ryvu to support BioNTech’s clinical trials for cancer in Poland

Ryvu will leverage its clinical network to streamline access to BioNTech’s investigational immunotherapies for Polish patients

Quotient Sciences and CPI to accelerate RNA drug development with joint venture

The JV will address the growing industry demand for agile solutions that bring new RNA therapeutics to patients with greater speed and confidence

Naobios, Nuvonis and the European Vaccine Initiative collaborate to manufacture influenza challenge agent

Working with the Inno4Vac consortium, Naobios will leverage Nuvonis’s Vero Cell Bank to support the development of a controlled human infection model based on the influenza virus A(H3N2)

Wegovy cuts risk of heart attack, stroke or death by 57% compared with tirzepatide

Study adds to growing evidence suggesting that the heart-protective benefits seen with Wegovy are specific to the semaglutide molecule and therefore cannot be extended to other GLP-1 or GIP/GLP-1-based treatments
You need to be a subscriber to read this article.
Click here to find out more.

Formulation meets function: addressing palatability in drug development (part I)

Patient adherence to treatment regimens is inextricably linked to the palatability of medications, with consequences that can be far more serious than simply leaving a bad taste in one’s mouth

Hamilton Health Sciences chosen for BirchBioMed burn scar treatment trial

BirchBioMed announces Hamilton Health Sciences’ (HHS) Centre for Burn Research in Ontario as the first contracted clinical trial site for its Phase II/III randomised study of the naturally based compound: FS2.

Indena and TCG GreenChem join forces to advance next-generation ADC technologies

Indena and TCG GreenChem are pleased to announce a new strategic collaboration aimed at accelerating the development of innovative and market-ready payload-linkers: the key component of antibody-drug conjugates (ADCs)

Sponsor content

Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision

Partnership delivers compliance confidence, efficiency gains and reduced waste

Meet Navetta: new approach to safety testing of drugs and particles

Turn inhalation research upside down

Sovereign demonstrates turnkey bottle labelling solution at PPMA Total Show 2025

Integrated labelling and tamper-proofing technologies showcased for high-speed production lines

Vapourtec unveils compact benchtop peptide synthesiser

Peptide-Builder uses VBFR technology to improve efficiency and reduce waste

LOCTITE to showcase next generation of healthcare adhesive innovations

New biocompatible adhesives aim to improve safety, performance, and sustainability

Shimadzu’s new UV-1900i Plus – smarter, faster UV-Vis spectrophotometer

Next-generation model offers ultra-fast scans and versatile measurement modes

Suncombe launches compact pH neutralisation systems for labs and small facilities

Expanded SUNpH range delivers compliance and performance in space-limited settings

One family’s journey from diagnosis to gene replacement therapy

How the Krueger family, supported by clinicians, researchers, and manufacturers, accelerated a novel treatment for ultra-rare NEDAMSS in just 14 months

Scalable chemistry and cross-sector expertise at CARBOGEN AMCIS Manchester

How the Manchester site delivers flexible solutions from early-phase synthesis to cosmetics GMP

Inhalytix+ streamlines cascade impaction data analysis

Copley launches connected software to automate inhaler testing workflows

Biotech Fluidics adds peristaltic tubing stop adapter to connector range

New adapter removes need for fixed stoppers and enables custom tubing lengths

New Clara plate combines cell culture and automation in one solution

Porvair Sciences launches 6-well format with integrated filtration options

Featured companies

Since 1974, Butterworth Laboratories has provided independent, contract analytical chemistry services to the global pharmaceutical and related industries. Consequently, we are... The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech... Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small-molecule and peptide drug... Andelyn Biosciences is a full-service cell and gene therapy CDMO focused on the development, characterization and production of viral vectors for gene therapy. With more than...
See more